AMT2003 drug page Clinical trials

Trials with AMT2003

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
2Countries
134Planned patients

Showing 1–2 of 2

Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003
Finished Phase 2 67 patients NCT00405561

The purpose of the study is to evaluate efficacy and safety of AMT2003 in cancer patients with advanced colorectal carcinoma. The primary endpoint is progression free survival rate at 18 weeks after registration

Germany Oct 2006 – Jan 2010 Interventional
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
Finished Phase 2 67 patients NCT00332280

The purpose of the study is to evaluate the efficacy and the safety of AMT2003 in cancer patients with advanced disease. The primary evaluation criterion is clinical benefit response.

Bosnia and Herzegovina, Germany May 2006 – Mar 2010 Interventional